Condition

AML, Childhood (3)

CBFA2T3-GLIS2-positive Acute Myeloid Leukemia (1)

Refractory Pediatric AML (1)

Relapsed Pediatric AML (1)

Overall Status

Active, not recruiting (2)

Not yet recruiting (1)

Sign in for free

Phase

phase 1 (2)

phase 1/phase 2 (1)

Sponsor

Elucida Oncology (1)

Therapeutic Advances in Childhood Leukemia Consortium (1)

Y-mAbs Therapeutics (1)

Collaborator

Bristol-Myers Squibb (1)

Children's Oncology Group (1)

Therapeutic Advances in Childhood Leukemia and Lymphoma (TACL) (1)

Intervention

5-azacytidine (1)

cd33*cd3 bsab (1)

elu001 (1)

nivolumab (1)

Study Documents

Intervention Type

drug (3)

Funder Type

Industry (2)

Other (1)

Study Type

Interventional (3)

aml, childhood

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

AML, Childhood Trial in United States (CD33*CD3 BsAb)

Active, not recruiting

AML, Childhood

CD33*CD3 BsAb

Birmingham, Alabama
+12 more

Jan 12, 2023

CBFA2T3-GLIS2-positive Acute Myeloid Leukemia, AML, Childhood, Relapsed Pediatric AML Trial (ELU001)

Not yet recruiting

CBFA2T3-GLIS2-positive Acute Myeloid Leukemia
+3 more

ELU001

(no location specified)

Nov 14, 2022

AML, Childhood Trial in United States (Nivolumab, 5-azacytidine)

Active, not recruiting

AML, Childhood

Los Angeles, California
+11 more

Oct 10, 2022